Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Classical hematology 1

Conditions

Breast Neoplasms 2354Neoplasms 1704Prostatic Neoplasms 1192Lung Neoplasms 922Colorectal Neoplasms 884Carcinoma, Non-Small-Cell Lung 866Leukemia, Myeloid, Acute 593Pancreatic Neoplasms 574Multiple Myeloma 551Carcinoma, Hepatocellular 516Brain Neoplasms 515Neoplasm Metastasis 461Head and Neck Neoplasms 457Melanoma 414Ovarian Neoplasms 412Glioblastoma 402Precursor Cell Lymphoblastic Leukemia-Lymphoma 398Stomach Neoplasms 376Uterine Cervical Neoplasms 362Squamous Cell Carcinoma of Head and Neck 362Rectal Neoplasms 342Recurrence 335Sarcoma 324Hematologic Neoplasms 324Colonic Neoplasms 321Lymphoma 320Triple Negative Breast Neoplasms 289Carcinoma, Renal Cell 283Urinary Bladder Neoplasms 281Glioma 280

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Shock, Septic × 1 year × Clear all
NCT07277387 2026-04-23

Plasma Host-Microbe Proteomics to Predict Complications in High-risk Febrile Neutropenia

Instituto de Investigación Biomédica de Salamanca

Not yet recruiting
350 enrolled
Classical hematologyOther hematologic neoplasm

Shock, Septic, Sepsis, Hematologic Neoplasms, Febrile Neutropenia

NCT03683329 2026-02-19

DéPOH

Institut Paoli-Calmettes

Phase 3 Completed
398 enrolled

Neoplasms, Shock, Septic, Sepsis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡